Liposomal muramyl tripeptide phosphatidyl ethanolamine: a safe and effective agent against osteosarcoma pulmonary metastases. - Wikidata - wikimedia - TriplyDB

Liposomal muramyl tripeptide phosphatidyl ethanolamine: a safe and effective agent against osteosarcoma pulmonary metastases.

Liposomal muramyl tripeptide phosphatidyl ethanolamine: a safe and effective agent against osteosarcoma pulmonary metastases.

http://www.wikidata.org/entity/Q34588395

about

Immune-based therapeutics for pediatric cancer.Review of mifamurtide in the treatment of patients with osteosarcoma.Muramyl tripeptide (mifamurtide) for the treatment of osteosarcoma.Mifamurtide for the treatment of nonmetastatic osteosarcoma Potential of human γδ T cells for immunotherapy of osteosarcoma.Current therapeutic strategies and novel approaches in osteosarcoma.Drugs in early clinical development for the treatment of osteosarcoma.Molecular alterations associated with osteosarcoma development.The elimination of MTC-220, a novel anti-tumor agent of conjugate of paclitaxel and muramyl dipeptide analogue, in rats.Expression and significance of secreted protein acidic and rich in cysteine in human osteosarcoma.Synergistic inhibitory effect of apomine and lovastatin on osteosarcoma cell growth.Progress in the chemotherapeutic treatment of osteosarcoma

P2860

Q33604121-213BB073-50A6-4D9D-8832-D55D53E247AF Q33947618-F394C9DF-A462-4617-8B1D-B464C8030DCD Q34996698-76CA9F48-9FB5-4B3C-A860-3C1A70F6C2E6 Q37827876-5E5073E3-5111-466D-8B77-B2ED18A8E0EE Q38052064-A05778C4-8488-4876-B988-71B0DFBAAA0E Q38161735-21BE4562-6A3B-4246-BAA0-F09354B9376B Q38955517-A7C15FAE-B750-4777-97B7-C423BA5C04DD Q42070262-5E223236-D0F7-4A92-B02C-E3AD5F8D9D33 Q46831381-75A480B5-D19C-4B10-9D8E-7D86743F7EFC Q47350176-C115C8DF-CE73-4979-8A4E-69EF69FB29DA Q53233606-E4D2BA2A-FD2B-481B-9E30-7599E5D9178C Q58572917-592DF355-61D0-486C-B3DB-BD9A39C5E52E

P2860

Liposomal muramyl tripeptide phosphatidyl ethanolamine: a safe and effective agent against osteosarcoma pulmonary metastases.

http://www.wikidata.org/entity/Q34588395

description

2008 nî lūn-bûn

@nan

2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Liposomal muramyl tripeptide p ...... osarcoma pulmonary metastases.

@ast

Liposomal muramyl tripeptide p ...... osarcoma pulmonary metastases.

@en

Liposomal muramyl tripeptide p ...... osarcoma pulmonary metastases.

@nl

type

label

Liposomal muramyl tripeptide p ...... osarcoma pulmonary metastases.

@ast

Liposomal muramyl tripeptide p ...... osarcoma pulmonary metastases.

@en

Liposomal muramyl tripeptide p ...... osarcoma pulmonary metastases.

@nl

prefLabel

Liposomal muramyl tripeptide p ...... osarcoma pulmonary metastases.

@ast

Liposomal muramyl tripeptide p ...... osarcoma pulmonary metastases.

@en

Liposomal muramyl tripeptide p ...... osarcoma pulmonary metastases.

@nl

P1433

Q34588395-20F30304-BC26-4211-8565-A17FB87EA89B

P1476

Q34588395-FCA4E4E6-34F7-47A8-AA99-8C50A8095254

P2093

Q34588395-0BD8F693-6A6D-40CE-BEBF-B4C7D86BCACE

Q34588395-9F4E96A2-2656-445C-AA64-F5E458BD70EE

P2860

Q34588395-090A3BF7-55F1-4F52-B8CD-721E0848EB73

Q34588395-237D9279-652F-4597-B98A-8239060D99EC

Q34588395-29189AC9-33CD-4F05-96BD-1E07AF8369BD

Q34588395-31B0A21A-58B7-42AB-921B-CD4C826BF781

Q34588395-3582F1A3-DA2A-4CDF-B554-FC31B48A65D8

Q34588395-3719F005-E114-4572-93E4-00294F9B0FF7

Q34588395-3734CF55-8492-4F27-95C5-508B6A115029

Q34588395-428421EF-5247-4FF1-A12A-79A1D6B8992C

Q34588395-445BC6B6-4BD7-4CBF-8627-9F8357DE1322

Q34588395-57100D07-C3F0-4546-9FC9-F2D4F42B1E89

P304

Q34588395-03765E6F-8C9E-431F-B408-DC947A682387

P31

Q34588395-8833F00D-A57E-4239-9D53-CD56CFD77427

P356

Q34588395-6954E863-32A2-4CDC-96D7-5772B2AD1FF2

P433

Q34588395-7A52D13D-DF12-4490-846B-83FCCD15F2EC

P478

Q34588395-D01FF498-4CCB-42A7-8DD9-0383E21B6A62

P50

Q34588395-0E286081-D8CE-4834-8FBC-7E6E97F6A36D

P577

Q34588395-054E30A8-F557-4E03-BC09-885F4015E82D

P698

Q34588395-492A4ED2-2532-4C48-8CF6-CFB078C591E2

P356

14737140.8.2.151

P1433

Expert Review of Anticancer Therapy

P1476

Liposomal muramyl tripeptide p ...... osarcoma pulmonary metastases.

@en

P2093

Kanji Mori

http://www.w3.org/2001/XMLSchema#string

Kosei Ando

http://www.w3.org/2001/XMLSchema#string

P2860

Phase I trial of liposomal muramyl tripeptide phosphatidylethanolamine in cancer patients

Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial.

Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.

Liposomal muramyl tripeptide (CGP 19835A lipid) therapy for resectable melanoma in patients who were at high risk for relapse: an update.

Overview of sarcomas in the adolescent and young adult population.

Liposomal muramyl tripeptide phosphatidylethanolamine: Targeting and activating macrophages for adjuvant treatment of osteosarcoma.

Influence of chemotherapy administration on monocyte activation by liposomal muramyl tripeptide phosphatidylethanolamine in children with osteosarcoma.

Therapy of human ovarian cancer xenografts with intraperitoneal liposome encapsulated muramyl-tripeptide phosphoethanolamine (MTP-PE) and recombinant GM-CSF.

Therapy for osteosarcoma in dogs with intravenous injection of liposome-encapsulated muramyl tripeptide.

Comparative pharmacokinetics of free muramyl tripeptide phosphatidyl ethanolamine (MTP-PE) and liposomal MTP-PE.

P304

151-159

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737140.8.2.151

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Dominique Heymann

P577

2008-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18279055

http://www.w3.org/2001/XMLSchema#string